Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Orally bioavailable CB2 receptor agonists attenuate neuroinflammation and stabilize the blood–brain barrier
Related
- CHBP-loaded mesoporous polydopamine nanoparticles attenuate neuroinflammation and reprogram microglia-neuron crosstalk for spinal cord injury repair
- Zinc Hexacyanoferrate Nanoenzymes Attenuate Neuroinflammation After Spinal Cord Injury by Modulating Mitochondrial Function and Microglial Polarization.
- Potential for GLP-1 Receptor Agonists in Irritable Bowel Syndrome
- Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention
- Divergent ocular safety profiles of glucagon-like peptide-1 receptor agonists: a pharmacological heterogeneity framework
BibTeX
@article{rom2026orally,
title = {{Orally bioavailable CB2 receptor agonists attenuate neuroinflammation and stabilize the blood–brain barrier}},
author = {Slava Rom and Viviana Zuluaga-Ramirez and Sachin Gajghate and Uwe Grether and Wolfgang Guba and Nancy L. Reichenbach and Mario Van der Stelt and Christoph Ullmer and Pal Pacher and Yuri Persidsky},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-77296-w},
url = {https://www.nature.com/articles/s41598-026-77296-w},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Orally bioavailable CB2 receptor agonists attenuate neuroinflammation and stabilize the blood–brain barrier
AU - Slava Rom
AU - Viviana Zuluaga-Ramirez
AU - Sachin Gajghate
AU - Uwe Grether
AU - Wolfgang Guba
AU - Nancy L. Reichenbach
AU - Mario Van der Stelt
AU - Christoph Ullmer
AU - Pal Pacher
AU - Yuri Persidsky
PY - 2026
DA - 2026/10/23
JO - Scientific Reports
DO - 10.1038/s41598-026-77296-w
UR - https://www.nature.com/articles/s41598-026-77296-w
SN - 2045-2322
ER -